Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 40.36% | 36.79% | -2.73% | 4.24% | -26.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.02% | 20.02% | -1.42% | 1.52% | -27.45% |
| Operating Income | -28.02% | -20.02% | 1.42% | -1.52% | 27.45% |
| Income Before Tax | 290.21% | 273.98% | -25.87% | 1.37% | 21.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 290.21% | 273.98% | -25.87% | 1.37% | 21.94% |
| Earnings from Discontinued Operations | 71.97% | -0.70% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 256.84% | 244.30% | -48.49% | -17.14% | 7.84% |
| EBIT | -28.02% | -20.02% | 1.42% | -1.52% | 27.45% |
| EBITDA | -48.34% | -40.63% | -6.39% | -7.00% | 34.32% |
| EPS Basic | 248.50% | 230.98% | -43.45% | -14.07% | 8.92% |
| Normalized Basic EPS | 39.62% | 7.99% | -21.03% | 4.28% | 22.86% |
| EPS Diluted | 248.50% | 230.98% | -43.45% | -14.07% | 8.92% |
| Normalized Diluted EPS | 39.62% | 7.99% | -21.03% | 4.28% | 22.86% |
| Average Basic Shares Outstanding | 12.59% | 6.74% | 4.69% | 2.64% | 0.71% |
| Average Diluted Shares Outstanding | 12.59% | 6.74% | 4.69% | 2.64% | 0.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |